The DOI matches its Crossref record; 190 of the 194 references it cites were found in a registry or an index; 91 of the 133 sources its claims cite were checked for support.
Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories
Open accessAbstract
In a subset of patients, chronic exposure to stress is an etiological risk factor for neuroinflammation and depression. Neuroinflammation affects up to 27% of patients with MDD and is associated with a more severe, chronic, and treatment-resistant trajectory. Inflammation is not unique to depression and has transdiagnostic effects suggesting a shared etiological risk factor underlying psychopathologies and metabolic disorders. Research supports an association but not necessarily a causation with depression. Putative mechanisms link chronic stress to dysregulation of the HPA axis and immune cell glucocorticoid resistance resulting in hyperactivation of the peripheral immune system. The chronic extracellular release of DAMPs and immune cell DAMP-PRR signaling creates a feed forward loop that accelerates peripheral and central inflammation. Higher plasma levels of inflammatory cytokines, most consistently interleukin IL-1β, IL-6, and TNF-α, are correlated with greater depressive symptomatology. Cytokines sensitize the HPA axis, disrupt the negative feedback loop, and further propagate inflammatory reactions. Peripheral inflammation exacerbates central inflammation (neuroinflammation) through several mechanisms including disruption of the blood-brain barrier, immune cellular trafficking, and activation of glial cells. Activated glial cells release cytokines, chemokines, and reactive oxygen and nitrogen species into the extra-synaptic space dysregulating neurotransmitter systems, imbalancing the excitatory to inhibitory ratio, and disrupting neural circuitry plasticity and adaptation. In particular, microglial activation and toxicity plays a central role in the pathophysiology of neuroinflammation. Magnetic resonance imaging (MRI) studies most consistently show reduced hippocampal volumes. Neural circuitry dysfunction such as hypoactivation between the ventral striatum and the ventromedial prefrontal cortex underlies the melancholic phenotype of depression. Chronic administration of monoamine-based antidepressants counters the inflammatory response, but with a delayed therapeutic onset. Therapeutics targeting cell mediated immunity, generalized and specific inflammatory signaling pathways, and nitro-oxidative stress have enormous potential to advance the treatment landscape. Future clinical trials will need to include immune system perturbations as biomarker outcome measures to facilitate novel antidepressant development. In this overview, we explore the inflammatory correlates of depression and elucidate pathomechanisms to facilitate the development of novel biomarkers and therapeutics.
Overview
CoChat Summary
TL;DR
This narrative review links chronic stress to HPA-axis dysregulation, immune-cell glucocorticoid resistance, DAMP-PRR signaling, peripheral and central inflammation, and depression. It argues that neuroinflammation defines a severe, treatment-resistant depressive subtype and reviews emerging anti-inflammatory and targeted immunomodulatory treatments.
Key findings
- Neuroinflammation affects up to 27% of patients with MDD and is associated with a more severe, chronic, treatment-resistant trajectory; peripheral CRP >3 mg/L is commonly used to subtype inflammation and correlates with CSF CRP.
- Chronic stress is proposed to drive HPA-axis dysregulation and glucocorticoid resistance, with elevated IL-1β, IL-6, and TNF-α; in preclinical work, peripheral IL-6 was 27 times higher in susceptible versus resilient mice after repeated social defeat stress, and anti-IL-6 before stress prevented social avoidance.
- Central effects include BBB disruption, glial activation, and neurotransmitter/network dysfunction; a meta-analysis estimated an 18% increase in TSPO availability in depressed patients, minocycline improved depression with effect sizes as high as 0.71, and MRI most consistently shows reduced hippocampal volumes.
- Anti-inflammatory augmentation may help: adjunctive anti-inflammatory treatment was reported as 52% more effective than placebo, celecoxib plus sertraline made response 7 times more likely, anti-cytokine treatment had a moderate effect size (Cohen’s d = 0.40), and infliximab reduced HAM-D at week 12 in patients with baseline CRP >5 mg/L.
Methods
- Narrative overview of pathophysiological mechanisms and emerging anti-inflammatories; no primary data collection or systematic review protocol is described.
- Synthesizes preclinical animal models, clinical observational studies, postmortem and neuroimaging findings, randomized trials, and meta-analyses.
- Main analysis is qualitative synthesis, with tables summarizing inflammatory mediators, proposed roles, and emerging therapeutic targets.
Limitations
- The paper states that evidence linking chronic stress, inflammation, and depression is largely observational and supports association but not necessarily causation.
- It states that anti-inflammatory data interpretation is limited by small numbers of studies, moderate to large heterogeneity, variations in diagnostic and treatment planning, and inclusion of patients without evidence of inflammation; targeted therapies are mostly limited to animal models or patients with autoimmune/rheumatological conditions.
- Evident from the text: as a narrative review, it does not describe a systematic search strategy, formal risk-of-bias assessment, or quantitative pooling of the reviewed literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
87 Valid · 8 Not valid · 42 Not checked · 27 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, persistent stress overstimulates the HPA axis causing an excess release of cortisol.”
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > Hypothalamic–pituitary–adrenal axis
What the sources say
- Supportedcites [16] Mikulska, 2021, HPA Axis in the Pathomechanism of depression and schizophrenia: new therapeutic strategies based on its participation, Brain Sci source
Section 7 states that chronic stress is associated with excessive activation of the HPA axis and that activation culminates in cortisol secretion. Section 3 also links chronic stress to elevated cortisol levels through HPA-axis dysregulation. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Clinical studies have corroborated that depressed patients have higher serum levels of IL-1β compared to non-depressed patients.”
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > Pattern-recognition receptors > NLRP3
What the sources say
- Partly supportedcites [51] Ferentinos, 2021, Interleukin-1 Beta in peripheral blood mononuclear cell lysates as a longitudinal biomarker of response to antidepressants: a pilot study, Front Psych sourceExperimental — accuracy not yet measured
The Discussion reports that a meta-analysis found higher circulating IL-1β in patients with major depressive disorder, but only among high-quality studies; it also says other meta-analyses found no significant difference. This study measured plasma rather than serum, and its Results found no significant patient–control difference in plasma IL-1β. It therefore does not support the unqualified claim about higher serum levels. (LLM, conf=0.86)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A meta-analysis reported higher levels of serum pro-inflammatory cytokines (IL-1β, IL-2, IL-6, IL-12, TNF-α) and reduced anti-inflammatory cytokines (IL-4, IL-10, transforming growth factor [TGF]-β1) in depressed compared to non-depressed patients (62).”
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > Cytokines
What the sources say
- Partly supportedcites [62] Osimo, 2020, Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls, Brain Behav Immun sourceExperimental — accuracy not yet measured
The Results (Mean differences) report higher IL-1β, IL-2, IL-6, IL-12 and TNF-α, and lower IL-4, in patients with depression than in controls. But they report higher—not lower—IL-10 and no significant difference in TGF-β, so the claimed reductions in those two markers are not supported. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Approximately 30% of patients with hepatitis C develop major depression within the first 3 months of receiving IFN-α (63).”
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > Cytokines
What the sources say
- Partly supportedcites [63] Chiu, 2017, Recurrence of depressive disorders after interferon-induced depression, Transl Psychiatry sourceExperimental — accuracy not yet measured
The Introduction says that up to 30% of IFN-α-treated patients with hepatitis C develop a major depressive episode within the first three months. The citing sentence preserves the population, condition and timing, but “approximately 30%” presents the source’s upper bound as an approximate rate. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The NLR3P inflammasome mediates proteolytic cleave of pro-caspase-1 leading to activation of caspase-1, which cleaves pro-interleukin 1β and 18 into their active cytokine forms (47).”
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > Pattern-recognition receptors > NLRP3
What the sources say
- Supportedcites [47] Guo, 2015, Inflammasomes: mechanism of action, role in disease, and therapeutics, Nat Med source
The NLRP3 inflammasome section says that pro-caspase-1 undergoes auto-proteolytic maturation into active caspase-1. The Introduction says active caspase-1 cleaves IL-1-family precursors into bioactive IL-1β and IL-18. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
99 more claims · 56 with their cited sources checked
Create a free account to see all 164 claims and every source verdict.
- It may state two separate claims as one. 50
- Probably not a substantial claim. 11
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > Cytokines
“Yamano and colleagues reversed INF-α induced stress susceptibility in mice with a corticotropin-releasing hormone receptor antagonist in a dose dependent fashion, suggesting that overactivity of the HPA axis mediates the cytokine depression response (64).”
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > References
“64. Yamano M Tohyama M. Distribution of corticotropin-releasing factor and calcitonin gene-related peptide in the developing mouse cerebellum.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > Damage-associated molecular patterns > S100B
“A 12-week randomized, placebo-controlled study found that pioglitazone, an insulin-sensitizing drug, improved glucose control and reduced chronic depression in patients with type II diabetes (28).”
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > References
“28. Li X Wilder-Smith CH Kan ME Lu J Cao Y Wong RK. Combat-training stress in soldiers increases S100B, a marker of increased blood-brain-barrier permeability, and induces immune activation.”
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 1×
“Activated macrophages and microglia release ROS that disrupt cell membranes, cellular DNA, and protein synthesis (101).”
BackgroundNitric oxide synthases: regulation and function
Forstermann, U., & Sessa, W. C. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr304 · Cited by 4,409 · cited 1×
“Nitrosative stress occurs when there is an abnormal increase in the level of nitric oxide (NO) produced by the inducible isoenzymes of NO synthase: neuronal, inducible, and endothelial (113).”
BackgroundThe NLRP3 Inflammasome: an overview of mechanisms of activation and regulation
Kelley, N., Jeltema, D., Duan, Y., & He, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133328 · Cited by 3,539 · cited 2×
“NLRP3 inflammasome (48) NLRP3 mediates proteolytic cleave of procaspase-1 leading to activation of caspase 1, IL-1β”
BackgroundDifferentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452 · cited 1×
“Treg cells suppress the immune response whereas Th cells trigger immunological responses (65).”
BackgroundInflammasomes: mechanism of action, role in disease, and therapeutics
Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340 · cited 2×
“Several PRRs, toll-like receptor-4 (TLR-4) and NLR family pyrin domain containing 3 (NLRP3), have been implicated in depression (47).”
BackgroundMechanisms, regulation and functions of the unfolded protein response
Hetz, C., Zhang, K., & Kaufman, R. J. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0250-z · Cited by 2,666 · cited 1×
“The function of the endoplasmic reticulum (ER) is to properly fold proteins and traffic them to various organelles and the cell membrane (37).”
BackgroundThe blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661 · cited 1×
“BMECs are connected to each other by tight junctions, GAP junctions, and adherens junctions (82).”
BackgroundThe Bidirectional Relationship of Depression and Inflammation: Double Trouble
Beurel, E., Toups, M., & Nemeroff, C. B. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.002 · Cited by 2,136 · cited 1×
“Modulation of NF-κB signaling is currently being investigated as an approach to treat major depression (80).”
BackgroundMarine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717 · cited 1×
“EPA and DHA ameliorate inflammation by inhibiting leukocyte chemotaxis, adhesion molecule expression, and the production of inflammatory cytokines and prostaglandins (164).”
Background
Cited by
PI3K/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression
Guo, N., Wang, X., Xu, M., Bai, J., Yu, H., & Zhang, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107300 · Cited by 218
Effects of chronic stress on cognitive function – From neurobiology to intervention
Girotti, M., Bulin, S. E., & Carreno, F. R. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100670 · Cited by 206
“We refer the interested reader to comprehensive reviews on the subject (Carrier et al., 2021; Godoy et al., 2018; Gray et al., 2017; Hassamal 2023; McEwen and Akil 2020).”
MethodSharma, S., Chawla, S., Kumar, P., Ahmad, R., & Verma, P. K. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149123 · Cited by 107
Treatment-resistant depression: molecular mechanisms and management
Kajumba, M. M., Kakooza‐Mwesige, A., Nakasujja, N., Attix, D. K., & Canli, T. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00205-y · Cited by 103
“The resulting DA and NE deficiency is associated with treatment‑resistant somatic symptoms subsequent desensitization of the HPA axis [139].”
BackgroundDepression and coronary heart disease: mechanisms, interventions, and treatments
Xu, L., Zhai, X., Shi, D., & Zhang, Y. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1328048 · Cited by 97
Liang, G., Kow, A. S. F., Yusof, R., Tham, C. L., Ho, Y.-C., & Lee, M. T. (2024) · Biomedicines · doi:10.3390/biomedicines12010184 · Cited by 68
“Conversely, ROS can also promote the synthesis and release of inflammatory factors [138], which creates a vicious neuroinflammation–ROS cycle.”
BackgroundSic, A., Cvetkovic, K., Manchanda, E., & Knezevic, N. N. (2024) · Diseases · doi:10.3390/diseases12090220 · Cited by 65
“Therefore, cortisol not only directly affects microglial activity and cytokine production but also indirectly modulates neuroinflammation through these additional mechanisms [118,119].”
BackgroundMicroglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression
Han, Q.-Q., Li, W., Chen, P., Wang, L., Bao, X., Huang, R., Liu, G., & Chen, X. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.390964 · Cited by 75
“For example, chronic psychological stress and depression-related alterations in the hypothalamic-pituitary-adrenal axis and cortisol levels may be responsible for activation of NLRP3 inflammasomes (Hassamal, 2023; Xia et al., 2023).”
BackgroundThe cortisol axis and psychiatric disorders: an updated review
George, M. Y., Mageed, S. S. A., Mansour, D. E., & Fawzi, S. F. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00782-x · Cited by 99
“Evidence suggests that the pathological effects of early life stress include not only lasting HPA axis dysregulation but also structural and functional brain changes, and heightened sus - ceptibility to neuroinflammatory processes [176, 181 ].”
Prediction of depressive disorder using machine learning approaches: findings from the NHANES
Vu, T., Yamamoto, M., Tay, J. T., Watanabe, N., Kuriya, Y., Oya, A., Hoang, P. T. N., & Araki, M. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-02903-1 · Cited by 72
Munteanu, C., Onose, G., Rotariu, M., Poştaru, M., Turnea, M. A., & Galaction, A. (2024) · Biomedicines · doi:10.3390/biomedicines12122670 · Cited by 63
“IBD, including Crohn’s disease and ulcerative colitis, is characterized by chronic inflammation of the gastrointestinal tract.”
Benítez-Agudelo, J. C., Restrepo, D., Navarro-Jiménez, E., & Clemente‐Suárez, V. J. (2025) · BMC Psychology · doi:10.1186/s40359-025-03041-z · Cited by 134
“Chronic stress induces dysregulation of the autonomic nervous system, characterized by a shift toward sympathetic dominance and a reduction in vagal tone, increasing vulnerability to cardiovascular and neurological disorders [19, 20].”
Blossom, V., Ullal, S. D., D’Souza, M. M., Ranade, A. V., Kumar, N. A., & Rai, R. (2025) · 3 Biotech · doi:10.1007/s13205-025-04468-2 · Cited by 62
“It is a well-known fact that chronic stress induces neuroinflammation (Hassamal 2023) and amygdala is the main region of the brain that mediates stress response and over stimulation of it results in anxiety and depression (Rosenkranz et al 2020; van den Bulk et al 2014).”
Mindfulness-Based Interventions and the Hypothalamic–Pituitary–Adrenal Axis: A Systematic Review
Vargas‐Uricoechea, H., Castellanos-Pinedo, A., Urrego-Noguera, K., Vargas-Sierra, H. D., Fernández, M. V. P., Barceló, E., & Giraldo, A. F. R. (2024) · Neurology International · doi:10.3390/neurolint16060115 · Cited by 62
“…pattern or are sustained over time, they have the opposite effect because they induce cellular damage and have been associated with outcomes such as depression, anxiety, post-traumatic stress, multiple metabolic and vascular diseases, chronic inflammation, autoimmunity and addictions [42,44–46].”
Mann, V., Sundaresan, A., & Shishodia, S. (2024) · Biology · doi:10.3390/biology13040241 · Cited by 54
“In depression, lipotoxicity contributes to chronic in fl ammation and oxidative stress, disrupting neuronal function and neurotrans-mi tt er balance, potentially exacerbating depressive symptoms [57].”
BackgroundSaggu, S., Pless, A., Dew, E., Ware, D., Jiao, K., & Wang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1543730 · Cited by 52
Modulation of neuroimmune cytokine networks by antidepressants: implications in mood regulation
Nava, R. G., Adri, A. S., Filgueiras, I. S., Nóbile, A. L., Barcelos, P. M., Corrêa, Y. L. G., de Oliveira, S. F., Cabral‐Miranda, G., Dias, H. D., Schimke, L. F., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03532-y · Cited by 57
Inflammatory markers and suicidal behavior: A comprehensive review of emerging evidence
Baldini, V., Gnazzo, M., Varallo, G., Atti, A. R., Ronchi, D. D., Fiorillo, A., & Plazzi, G. (2025) · Annals of General Psychiatry · doi:10.1186/s12991-025-00575-9 · Cited by 46
“These findings align with the broader literature suggesting that chronic inflammation is implicated in psychiatric disorders, particularly major depressive disorder [45, 46].”
Shen, C., Wang, K., Wang, H., Gao, Y., Nie, K., Jiang, X., Su, H., Tang, Y., Lu, F., Dong, H., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107090 · Cited by 38
Kruszka, J., Martyński, J., Szewczyk‐Golec, K., Woźniak, A., & Nuszkiewicz, J. (2025) · Brain Sciences · doi:10.3390/brainsci15050485 · Cited by 47
“As a result, synaptic dysfunction develops, impeding memory formation and cognitive processes [42].”
Critical Review of the Cross-Links Between Dietary Components, the Gut Microbiome, and Depression
Randeni, N., & Xu, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020614 · Cited by 46
Geng, M., Shao, Q., Fu, J., Gu, J., Feng, L., Zhao, L., Liu, C., Mu, J., Zhang, X., Zhao, M., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02846-7 · Cited by 35
From Stress to Synapse: The Neuronal Atrophy Pathway to Mood Dysregulation
Krasner, H., Ong, C. V., Hewitt, P., & Vida, T. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073219 · Cited by 42
“However, chronic stress and neuroinflammation induce a shift toward a pro-inflammatory phenotype, leading to excessive synaptic pruning and neuronal atrophy [99,100].”
InfluentialChaudhary, R., Prasad, A., Agarwal, V., Rehman, M., Kumar, A., Kaushik, A. S., Srivastava, S., Srivastava, S., & Mishra, V. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111046 · Cited by 45
Rábago-Monzón, Á. R., Osuna‐Ramos, J. F., Armienta-Rojas, D. A., Camberos-Barraza, J., Camacho-Zamora, A., Magaña‐Gómez, J. A., & la Herrán-Arita, A. K. D. (2025) · Biomedicines · doi:10.3390/biomedicines13051121 · Cited by 43
“Chronic stress disrupts glial homeostasis, neuroinflammatory pathways, and neurotransmitter balance, exacerbating sleep dysfunction and psychiatric symptoms [98].”
Yang, S., Chen, L., Zhang, H., Song, Y., Wang, W., Hu, Z., Wang, S., Huang, L., Wang, Y., Wu, S., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03397-4 · Cited by 34
“Moreover, the act of scratching elicits pleasure that is stored in memory by various regions of the brain, including the hippocampus, VTA, and amygdala, ultimately impacting behavior by reinforcing the habit of scratching increased inflammatory responses [149–151].”
How inflammation influences psychiatric disease
Ferat-Osorio, E. A., Maldonado-García, J. L., & Pavón, L. (2024) · World Journal of Psychiatry · doi:10.5498/wjp.v14.i3.342 · Cited by 31
Weaver, D. F. (2023) · Brain Sciences · doi:10.3390/brainsci14010041 · Cited by 39
“In depression, chronic activation of innate immunity accelerates central inflammation, leading to higher levels of inflammatory cytokines, most consistently IL-1 β , IL-6 and TNF α , which, in turn, correlates with greater depressive symptomatology [130].”
BackgroundJie, S., Fu, A., Wang, C., & Rajabi, S. (2025) · Behavioral and Brain Functions · doi:10.1186/s12993-025-00273-2 · Cited by 41
Linking depression and neuroinflammation: Crosstalk between glial cells
Yang, X., Wang, H., Wang, Z.-Z., & Chen, N. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177408 · Cited by 27
New insights into anti-depression effects of bioactive phytochemicals
Zhao, R., Wang, J., Chung, S. K., & Xu, B. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107566 · Cited by 31
Molecular mechanisms underlying major depressive disorder and post-stroke affective disorders
Coliță, D., Burdusel, D., Glăvan, D., Hermann, D. M., Coliță, C.-I., Coliță, E., Udriștoiu, I., & Popa‐Wagner, A. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.10.037 · Cited by 28
The gut–brain–circadian axis in anxiety and depression: a critical review
Bautista, J., Hidalgo‐Tinoco, C., Delgado, M. D. C., Viteri-Recalde, J., Guerra-Guerrero, A., & López‐Cortés, A. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1697200 · Cited by 46
The involvement of neuroinflammation in an animal model of dementia and depression
Zabot, G. C., Medeiros, E. B., Macarini, B. M. N., Peruchi, B. B., Keller, G. S., Lídio, A. V., Boaventura, A. L., de Jesus, L. C., Silveira, G. D. B., Silveira, P. C. L., et al. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.110999 · Cited by 26
Bertollo, A. G., Galvan, A. C. L., Dallagnol, C., Cortez, A. D., & Ignácio, Z. M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03983-2 · Cited by 25
“…role in the nervous system, where they are of paramount importance for the optimal functioning of the brain, their constant exposure can cause recognized brain changes in triggering MDD. Studies indicate the increase of these cytokines in the cerebrospinal fluid of depressed individuals [24].”
Zheng, Y., & Xu, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1646740 · Cited by 34
Dan, Y., Xiong, Y., Xu, D., Wang, Y., Yin, M., Sun, P., Ding, Y., Feng, Z., Sun, P., Xia, W., et al. (2025) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2025.1471433 · Cited by 29
“…neurotransmitters, chemokine receptors, the endogenous opioid peptide system, and the gut microbiome-brain axis are all potential mechanisms underlying NPDs (Conti and Shaik-Dasthagirisaheb, 2015; Hassamal, 2023; Malan-Muller et al., 2022; Saggu et al., 2024; Torres-Berrio and Nava-Mesa, 2019).”
NADPH-oxidases as potential pharmacological targets for thrombosis and depression comorbidity
Amadio, P., Sandrini, L., Zarà, M., Barbieri, S. S., & Ieraci, A. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103060 · Cited by 28
“Depression is a complex mental illness involving various molecular and cellular mechanisms in the brain [87,88].”
BackgroundBlood-brain barrier biomarkers
Zapata-Acevedo, J. F., Mantilla-Galindo, A., Vargas-Sánchez, K., & González-Reyes, R. E. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.04.004 · Cited by 28
Muhammad, R. N., Albahairy, M. A., Fattah, M. A. A. E., & Ibrahim, W. W. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06663-0 · Cited by 27
“These released ILs have been strongly associated with stress response and depression by means of inhibiting hippocampal neurogenesis and disrupting neural networks that are involved in reward processing (Hassamal 2023).”
Liu, H., Xiang, R., & Chen, Z. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.037 · Cited by 27
Cavalu, S. D., Saber, S., Ramadan, A., Elmorsy, E. A., Hamad, R. S., Abdel‐Reheim, M. A., & Youssef, M. E. (2024) · The FASEB Journal · doi:10.1096/fj.202400823r · Cited by 29
Angelopoulou, E., Koros, C., Hatzimanolis, A., Stefanis, L., Scarmeas, N., & Papageorgiou, S. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052645 · Cited by 25
Saeed, D. K., & Nashwan, A. J. (2025) · Cureus · doi:10.7759/cureus.85580 · Cited by 38
“Chronic stress, when unmitigated, contributes to systemic inflammation and is implicated in a wide range of conditions, from depression to hypertension [7].”
Neuroinflammation and Natural Antidepressants: Balancing Fire with Flora
Godoy, A. C. F., Frota, F. F., Araújo, L. P., Valenti, V. E., Pereira, E. D. S. B. M., Detregiachi, C. R. P., Galhardi, C. M., Caracio, F. C. C., Haber, R. S. A., Laurindo, L. F., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13051129 · Cited by 46
“Emerging data suggest that neuroinflammation plays a critical role in the pathophysiology of MDD, particularly in its more severe and treatment-resistant forms [47].”
InfluentialFeng, L.-S., Wang, Y., Liu, H., Ning, B., Yu, H.-B., Li, S., Wang, Y., Zhao, M., & Ma, J. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2312222 · Cited by 39
“Elevated oxidative stress (at a later time) by long-term elevations in levels of NOX2expression, as well as the adrenal glands, might determine alterations in peripheral biomarkers (plasma and salivary CORT) of the HPA axis [85].”
Impact of corticoid receptors on Alzheimer’s disease: a neuroendocrine perspective
Goel, F., Kumar, D., & Sharma, A. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01734-w · Cited by 30
The Neurovascular Unit as a Locus of Injury in Low-Level Blast-Induced Neurotrauma
Elder, G. A., Sosa, M. A. G., Gasperi, R. D., Garcia, G. S. P., Perez, G. M., Abutarboush, R., Kawoos, U., Zhu, C. W., Janssen, W. G. M., Stone, J. R., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021150 · Cited by 26
Combining inflammatory miRNA molecules as diagnostic biomarkers for depression: a clinical study
Brás, J. P., Pinto, S., von Doellinger, O., Prata, J., Coelho, R. C., Barbosa, M. A., Almeida, M. I., & Santos, S. G. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1227618 · Cited by 23
“A segment of depression patients exhibits chronic inflammation, shown by increased systemic levels of inflammation-related markers, including cytokines and other inflammatory mediators, such as C-Reactive Protein (CRP), which have been correlated with more severe depression symptoms (8, 36).”
BackgroundThe Role of Neuroinflammation in the Comorbidity of Psychiatric Disorders and Internal Diseases
Cătălina, G. R., Gheorman, V., Gheorman, V., & Forțofoiu, M.-C. (2025) · Healthcare · doi:10.3390/healthcare13070837 · Cited by 32
“This chronic hypertensive state not only damages vascular integrity but also feeds back into the anxiety pathway by exacerbating neuroinflammation and disrupting stress-regulating neural circuits, such as the prefrontal cortex and amygdala [108].”
Sleep deprivation-induced shifts in gut microbiota: Implications for neurological disorders
Wankhede, N. L., Kale, M. B., Kyada, A., Rekha, M. M., Chaudhary, K., Naidu, K. S., Rahangdale, S. R., Shende, P. V., Taksande, B. G., Khalid, M., et al. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.070 · Cited by 23
Zhu, Y., & Fu, Z. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06178-0 · Cited by 22
“These cytokines can cross the blood-brain barrier and trigger neuroimmune responses in the central nervous system, leading to neuroinflammation, which directly causes neuronal damage [21].”
BackgroundKoreki, A., Sado, M., Mitsukura, Y., Tachimori, H., Kubota, A., Kanamori, Y., Uchibori, M., Usune, S., Ninomiya, A., Shirahama, R., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-70834-4 · Cited by 24
“Under inflammatory conditions, activation of glial cells and the subsequent alteration of the kynurenine pathway leads to an increase in quinolinic acid, which has neurotoxic effects, whereas the synthesis of neuroprotective kynurenic acid is reduced 28,60–62 .”
BackgroundFibromyalgia, Depression, and Autoimmune Disorders: An Interconnected Web of Inflammation
Sedda, S., Cadoni, M. P. L., Medici, S., Aiello, E., Erre, G. L., Nivoli, A. M., Carru, C., & Coradduzza, D. (2025) · Biomedicines · doi:10.3390/biomedicines13020503 · Cited by 22
Association between the triglyceride glucose index and depression: a meta-analysis
Wan, W., & Yu, Y. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1390631 · Cited by 21
Heartbeats and high scores: esports triggers cardiovascular and autonomic stress response
Ketelhut, S., & Nigg, C. R. (2024) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2024.1380903 · Cited by 24
The gut–brain connection: microbes’ influence on mental health and psychological disorders
Ataei, P., Kalantari, H., Bodnar, T. S., & Turner, R. J. (2026) · Frontiers in Microbiomes · doi:10.3389/frmbi.2025.1701608 · Cited by 41
“Chronic in fl ammation has been linked to alterations in neurotransmitter signaling, oxidative stress, and impaired neuroplasticity, all of which are associated with mental health disorders (Hassamal, 2023).”
Ruohan, Z., Ruting, W., Hongxi, W., Zhenjin, H., Jiale, L., Rongxin, Z., Jiang, F., & Yuanbo, S. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1664800 · Cited by 19
“This cascade results from dysfunction of the HPA axis, disturbing gut bacterial balance (Hassamal, 2023).”
Mechanistic intersections between migraine and major depressive disorder
Johnson, M., Filali, Y., Adegboyo, A., Eberle, M., Townsend, A., Hussien, Y., Marcinkiewcz, C. A., & Hultman, R. C. (2025) · The Journal of Headache and Pain · doi:10.1186/s10194-025-02097-x · Cited by 17
“In MDD, extensive studies have investigated a role for HPA-axis in the development of pathology relating to its impact on neuroplasticity, neurotransmitter systems, immune response, metabolism, oxidation, and gut microbiota [284, 339– 341].”
Carrera‐Bastos, P., Silva, B. M. B. D. M., Stults‐Kolehmainen, M., Schuch, F. B., Ordóñez, F. M., Müller, P. D. T., Blanco, J. R., & Boullosa, D. A. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1554062 · Cited by 22
“Dysregulation of inflammatory pathways has been proposed as a possible link between prolonged stress exposure and the development of depressive-like conditions in this context, though conclusive evidence is still lacking (Kim et al., 2022; Hassamal, 2023).”
Song, X., Zhu, H., Chen, Z., Wang, Y., Zhang, J., Wang, Y., Rong, P., & Wang, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1536056 · Cited by 27
Lee, D.-Y., Baek, J.-S., Shin, Y.-J., & Kim, D. H. (2024) · Nutrients · doi:10.3390/nu16213711 · Cited by 22
“Chronic exposure to stress, including social defeat and immobilization, triggers the release of adrenal hormones like noradrenaline, adrenaline, and glucocorticoids, as well as proinflammatory cytokines like TNF-α and IL-6, leading to depression and anxiety (DA) [1,2].”
Neuroimmunological effects of omega-3 fatty acids on migraine: a review
Chen, T., Yang, C., Tsai, I., Yang, H.-W., Hsu, Y., Chang, C., & Yang, C. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1366372 · Cited by 26
Singhal, G., Singhal, S., & Baune, B. T. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70009 · Cited by 26
Zhang, Q., Zhang, S., Cao, X., Zhi, Y., & Guo, Y. C. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128391 · Cited by 19
Sleep Disorders: Pathogenesis and Therapeutic Interventions
Liu, C., He, Z., Wu, Y., Liu, Y., Li, Z., Jia, Y., & Xiang, H. (2025) · MedComm · doi:10.1002/mco2.70130 · Cited by 22
“Uponactivation, glial cells discharge cytokines, chemokines, and reactive oxygen and nitrogen species into the extrasynaptic region, leading to dysregulation of neurotransmitter systems, imbalance of excitation to inhibition ratios, and disruption of neural circuit plasticity and adaptation [14].”
Wei, J., Liu, C., Qin, D., Ren, F., Duan, J., Chen, T., & Wu, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102544 · Cited by 15
Gao, Y., Pan, K., Zhang, Y.-M., Qi, Y., Chen, W.-G., Zhou, T. J., Zong, H.-C., Guo, H., Zhao, J.-W., Liu, X., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01384-8 · Cited by 19
Tripathi, A., Bartosh, A., Mata, J., Jacks, C., Madeshiya, A. K., Hussein, U. K., Hong, L. E., Zhao, Z., & Pillai, A. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02675-6 · Cited by 18
Ghrelin, Neuroinflammation, Oxidative Stress, and Mood Disorders: What Are the Connections?
Mingardi, J., Meanti, R., Paoli, C., Cifani, C., Torsello, A., Popoli, M., & Musazzi, L. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22999240722095039 · Cited by 16
Gędek, A., Modrzejewski, S., Materna, M., Iwański, M., Wichniak, A., & Dominiak, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110362 · Cited by 27
Cherneva, D. I., Kehayova, G. K., Dimitrova, S., & Dragomanova, S. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090710 · Cited by 23
“Prolonged stress and inflammation can impair the functioning of the HPA axis, leading to altered cortisol secretion [128].”
Yun, S.-W., Shin, Y.-J., Ma, X., & Kim, D. (2024) · Nutrients · doi:10.3390/nu16223810 · Cited by 14
Depressive symptoms and the development of hypertension
Inoue, T. (2024) · Hypertension Research · doi:10.1038/s41440-024-01856-8 · Cited by 18
Single-cell RNA-seq reveals the role of YAP1 in prefrontal cortex microglia in depression
Ma, F., Bian, H., Jiao, W., & Zhang, N. (2024) · BMC Neurology · doi:10.1186/s12883-024-03685-1 · Cited by 17
“Additionally, we identified differences in microglia between the two species, such as CD family expression levels, which may provide new clues and potential therapeutic targets for human depression research [28, 29].”
BackgroundNguyen, L. T. H., Nguyen, N. P. K., Tran, K. N., Choi, H. J., Moon, I. S., Shin, H., & Yang, I. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116164 · Cited by 18
Chronic stress, gut microbiota, and immunity: interconnections and implications for health
Jia, H., Guo, X., Wei, Y., Can, C., He, N., Zhang, H., Yang, X., Wu, H., Liu, W., & Ma, D. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05376-y · Cited by 15
“Chronic stress alters the neuroendocrine system [8], immunological system [55, 64, 65], and neurotransmitter systems [13, 66].”
InfluentialWang, T., Wang, X., Wang, K., Yu, M., Bai, R., Zhang, Y., Zhang, Z., Liu, F., Wang, R., Shi, X., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2415042122 · Cited by 18
Ren, Q., He, C., Sun, Y., Gao, X., Zhou, Y., Qin, T., Zhang, Z., Wang, X., Wang, J., Wei, S., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1461873 · Cited by 16
“Conversely, certain cytokines such as IL-6 and TNF-α may pass through the BBB and activate the HPA axis (Banks, 2005; Hassamal, 2023).”
BackgroundDragasevic, S., Stankovic, B., Kotur, N., Sokic Milutinovic, A., Nikolic, A., Pavlovic, S., & Popovic, D. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae180 · Cited by 13
Niazi, N. U. K., Huang, C.-Y., Yang, Z., Zhang, Y., & Song, C. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115067 · Cited by 17
Li, J., Wan, B., Zhou, L., Qian, X., Wang, F., Gu, S., Ma, X., & Huang, J. H. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1629182 · Cited by 26
Young, V. M., Bernal, R., Baril, A., Zeynoun, J., Wiedner, C. D., Gaona, C. A., Beiser, A., Teixeira, A. L., Salardini, A., Pase, M. P., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70160 · Cited by 18
“58,59 In those with depression, the HPA axis is usually hyperactive, potentially leading to fragmented sleep and reduced SWS duration.”
Enhancement of glymphatic function and cognition in chronic insomnia using low-frequency rTMS
Zhang, C., Zheng, Y., Jiang, G., Luo, J., Su, L., Ai, Y., Feng, C., Li, C., Li, S., & Hu, X. (2025) · SLEEP · doi:10.1093/sleep/zsaf083 · Cited by 16
Ho, S., Hsiao, I., Lin, K., Wu, Y., & Wu, K. (2024) · Brain and Behavior · doi:10.1002/brb3.70016 · Cited by 12
“Research indicates that individuals with depression exhibit heightened levels of C-reactive protein, pro-inflammatory cytokines such as interleukin (IL)-1, IL-6, and tumor necrosis factor-alpha (TNF-α ), along with chemokines (Dowlati et al., 2010).”
BackgroundInfluentialImpaired Modulation of the Autonomic Nervous System in Adult Patients with Major Depressive Disorder
Böttcher, E., Schreiber, L. S., Wozniak, D., Scheller, E., Schmidt, F. M., & Pelz, J. O. (2024) · Biomedicines · doi:10.3390/biomedicines12061268 · Cited by 17
“Chronic stress is a risk factor for MDD and, in particular, for the melancholic phenotype of depression [26].”
BackgroundLee, K., Kim, M., Yuk, H. J., Jo, Y., Kim, H. J., Kim, J., Kim, H., Shin, J., Kim, D., & Park, K.-S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116770 · Cited by 17
NLRP3 Inflammasome Triggers Inflammation of Obstructive Sleep Apnea
Yangzhong, X., Hua, S., Wen, Y., Bi, X., Li, M., Zheng, Y., & Sun, S. (2024) · Current Molecular Medicine · doi:10.2174/0115665240294605240426123650 · Cited by 14
Hu, Y., Ali, T., Mou, S., Gong, Q., Gao, R., Luo, Y., Li, S., Li, L., & Hao, L. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10180-y · Cited by 12
“Although acute inflammation functions as a protective response, persistent or excessive inflammation in the brain can lead to harmful effects and is implicated in a range of neurological and psychiatric disorders, including depression (Furman et al. 2019; Hassamal 2023).”
Interconnections of screen time with neuroinflammation
Verma, A., Kumar, A., Chauhan, S. S., Sharma, N., Kalani, A., & Gupta, P. C. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05123-9 · Cited by 20
Allopregnanolone and its antagonist modulate neuroinflammation and neurological impairment
Bäckström, T. C., Doverskog, M., Blackburn, T. P., Scharschmidt, B. F., & Felipo, V. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105668 · Cited by 16
“In contrast, during fetal development the intracellular Cl-concentration is comparably high, and because of that activation of GABA-A-receptors causes excitation (Kahle et al., 2008).”
Backgroundα-synuclein in Parkinson’s disease: a central point of convergence with depression
Yusuf, A. M., İlçe, B. Y., Alhaj, H. A., & Hamoudi, R. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01167-w · Cited by 20
Nagpurkar, K., Ghive, P., Kale, M. B., Nistane, N. T., Taksande, B. G., Umekar, M. J., & Trivedi, R. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.05.022 · Cited by 12
Xing, S., Xu, S., Wang, L., Guo, L., Zhou, X., Wu, H., Wang, W., & Liu, L. (2024) · Acta Neuropsychiatrica · doi:10.1017/neu.2024.28 · Cited by 11
“The enhancement of synaptic protein expression, axon remodelling, neurotrophic, glial density and hippocampal pyramidal neurons are the microcosmic basis of antidepressant effects (Hassamal, 2023).”
Lai, G., Malavolta, M., Marcozzi, S., Bigossi, G., Giuliani, M. E., Casoli, T., & Balietti, M. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02935-7 · Cited by 11
Murthy, M. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.009 · Cited by 13
Daksh, R., Sharma, P., Khanna, S., Mudgal, J., Hariharapura, R. C., & Nampoothiri, M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142829 · Cited by 12
Gut–brain axis in health and brain disease
Olasunkanmi, O. I., Zheng, L., & Zheng, P. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003920 · Cited by 14
“[22] These behavioral altera-tions—including fatigue, reduced motivation, anhedonia, and cognitive deficits—were not merely byproducts of illness but were later found to be actively mediated by inflammatory cytokines.”
Liu, Y., Ding, X., Younas, A., Sun, X., Ni, X., Wang, S., Lv, J., Li, Z., & Shao, C. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157221 · Cited by 14
Zhang, Z., Ruan, X.-Y., & Ma, W. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1510218 · Cited by 11
Metadata
- Authors
- Hassamal, S.
- Affiliations
- California University of Science and Medicine (US)
- Corresponding author
- Hassamal, Sameer
- ORCID
- Hassamal, Sameer
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2023-05-11
- Volume
- 14
- Pages
- 1130989-1130989
- ISSN
- 1664-0640 (ISSN-L)
- PMC
- PMC10213648
- OpenAlex
- W4376279472
- Semantic Scholar
- 38bc0fd145aaecf15f84b2c481c52f74bd9d9788
- Cited by
- 578
- References
- 194
- Citations by year
- 2026: 223 · 2025: 239 · 2024: 103 · 2023: 13
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- chronic stress, neuroinflammation, depression, major depressive disorder, HPA axis dysregulation, glucocorticoid resistance, peripheral inflammation, cytokines, blood-brain barrier, microglial activation, glial cells, hippocampal volume, ventral striatum, ventromedial prefrontal cortex, nitro-oxidative stress, inflammatory markers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.